Literature DB >> 19489890

Sumatriptan alleviates nitroglycerin-induced mechanical and thermal allodynia in mice.

E A Bates1, T Nikai, K C Brennan, Y-H Fu, A C Charles, A I Basbaum, L J Ptácek, A H Ahn.   

Abstract

The association between the clinical use of nitroglycerin (NTG) and headache has led to the examination of NTG as a model trigger for migraine and related headache disorders, both in humans and laboratory animals. In this study in mice, we hypothesized that NTG could trigger behavioural and physiological responses that resemble a common manifestation of migraine in humans. We report that animals exhibit a dose-dependent and prolonged NTG-induced thermal and mechanical allodynia, starting 30-60 min after intraperitoneal injection of NTG at 5-10 mg/kg. NTG administration also induced Fos expression, an anatomical marker of neuronal activity in neurons of the trigeminal nucleus caudalis and cervical spinal cord dorsal horn, suggesting that enhanced nociceptive processing within the spinal cord contributes to the increased nociceptive behaviour. Moreover, sumatriptan, a drug with relative specificity for migraine, alleviated the NTG-induced allodynia. We also tested whether NTG reduces the threshold for cortical spreading depression (CSD), an event considered to be the physiological substrate of the migraine aura. We found that the threshold of CSD was unaffected by NTG, suggesting that NTG stimulates migraine mechanisms that are independent of the regulation of cortical excitability.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19489890      PMCID: PMC4854191          DOI: 10.1111/j.1468-2982.2009.01864.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  48 in total

1.  Observations on 500 cases of migraine and allied vascular headache.

Authors:  G SELBY; J W LANCE
Journal:  J Neurol Neurosurg Psychiatry       Date:  1960-02       Impact factor: 10.154

2.  Hypoalgesia and hyperalgesia with inherited hypertension in the rat.

Authors:  B K Taylor; R E Roderick; E St Lezin; A I Basbaum
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2001-02       Impact factor: 3.619

3.  A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia.

Authors:  K Hargreaves; R Dubner; F Brown; C Flores; J Joris
Journal:  Pain       Date:  1988-01       Impact factor: 6.961

4.  The prophylactic effect of valproate on glyceryltrinitrate induced migraine.

Authors:  J F Tvedskov; L L Thomsen; H K Iversen; A Gibson; P Wiliams; J Olesen
Journal:  Cephalalgia       Date:  2004-07       Impact factor: 6.292

5.  Prevalence and characteristics of allodynia in headache sufferers: a population study.

Authors:  M E Bigal; S Ashina; R Burstein; M L Reed; D Buse; D Serrano; R B Lipton
Journal:  Neurology       Date:  2008-04-22       Impact factor: 9.910

Review 6.  Nitric oxide (NO) and nociceptive processing in the spinal cord.

Authors:  S T Meller; G F Gebhart
Journal:  Pain       Date:  1993-02       Impact factor: 6.961

7.  Profound reduction of somatic and visceral pain in mice by intrathecal administration of the anti-migraine drug, sumatriptan.

Authors:  Tetsuro Nikai; Allan I Basbaum; Andrew H Ahn
Journal:  Pain       Date:  2008-08-23       Impact factor: 6.961

8.  Episodic dural stimulation in awake rats: a model for recurrent headache.

Authors:  Michael L Oshinsky; Sumittra Gomonchareonsiri
Journal:  Headache       Date:  2007 Jul-Aug       Impact factor: 5.887

9.  Effect of a nitric oxide donor (glyceryl trinitrate) on nociceptive thresholds in man.

Authors:  L L Thomsen; J Brennum; H K Iversen; J Olesen
Journal:  Cephalalgia       Date:  1996-05       Impact factor: 6.292

10.  A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression.

Authors:  Arn M J M van den Maagdenberg; Daniela Pietrobon; Tommaso Pizzorusso; Simon Kaja; Ludo A M Broos; Tiziana Cesetti; Rob C G van de Ven; Angelita Tottene; Jos van der Kaa; Jaap J Plomp; Rune R Frants; Michel D Ferrari
Journal:  Neuron       Date:  2004-03-04       Impact factor: 17.173

View more
  82 in total

1.  Altered brainstem auditory evoked potentials in a rat central sensitization model are similar to those in migraine.

Authors:  Xianghong Arakaki; Gary Galbraith; Victor Pikov; Alfred N Fonteh; Michael G Harrington
Journal:  Brain Res       Date:  2014-03-27       Impact factor: 3.252

2.  The effects of acute and preventive migraine therapies in a mouse model of chronic migraine.

Authors:  Alycia F Tipton; Igal Tarash; Brenna McGuire; Andrew Charles; Amynah A Pradhan
Journal:  Cephalalgia       Date:  2016-07-19       Impact factor: 6.292

Review 3.  Update on animal models of migraine.

Authors:  Marcela Romero-Reyes; Simon Akerman
Journal:  Curr Pain Headache Rep       Date:  2014-11

Review 4.  Animal models of chronic migraine.

Authors:  Robin James Storer; Weera Supronsinchai; Anan Srikiatkhachorn
Journal:  Curr Pain Headache Rep       Date:  2015-01

5.  Non-invasive dural stimulation in mice: A novel preclinical model of migraine.

Authors:  Carolina Christina Burgos-Vega; Lilyana D Quigley; Gabriela Trevisan Dos Santos; Flora Yan; Marina Asiedu; Blaine Jacobs; Marina Motina; Nida Safdar; Hayyan Yousuf; Amanda Avona; Theodore John Price; Greg Dussor
Journal:  Cephalalgia       Date:  2018-05-31       Impact factor: 6.292

6.  Effects of systemic inhibitors of acid-sensing ion channels 1 (ASIC1) against acute and chronic mechanical allodynia in a rodent model of migraine.

Authors:  Clément Verkest; Emilie Piquet; Sylvie Diochot; Mélodie Dauvois; Michel Lanteri-Minet; Eric Lingueglia; Anne Baron
Journal:  Br J Pharmacol       Date:  2018-09-22       Impact factor: 8.739

7.  Gut Microbiota Dysbiosis Enhances Migraine-Like Pain Via TNFα Upregulation.

Authors:  Yuanyuan Tang; Sufang Liu; Hui Shu; Lora Yanagisawa; Feng Tao
Journal:  Mol Neurobiol       Date:  2019-08-04       Impact factor: 5.590

Review 8.  Does sumatriptan cross the blood-brain barrier in animals and man?

Authors:  Peer Carsten Tfelt-Hansen
Journal:  J Headache Pain       Date:  2009-12-10       Impact factor: 7.277

9.  The role of regulator of G protein signaling 4 in delta-opioid receptor-mediated behaviors.

Authors:  Isaac J Dripps; Qin Wang; Richard R Neubig; Kenner C Rice; John R Traynor; Emily M Jutkiewicz
Journal:  Psychopharmacology (Berl)       Date:  2016-09-13       Impact factor: 4.530

10.  δ-Opioid receptor agonists inhibit migraine-related hyperalgesia, aversive state and cortical spreading depression in mice.

Authors:  Amynah A Pradhan; Monique L Smith; Jekaterina Zyuzin; Andrew Charles
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.